Truvvo Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,500
Closed -$611K 47
2018
Q3
$611K Hold
2,500
0.38% 28
2018
Q2
$519K Sell
2,500
-4,100
-62% -$870K 0.34% 35
2018
Q1
$1.36M Hold
6,600
0.5% 46
2017
Q4
$1.25M Hold
6,600
0.42% 55
2017
Q3
$1.25M Hold
6,600
0.41% 52
2017
Q2
$1.15M Hold
6,600
0.42% 57
2017
Q1
$1.01M Buy
6,600
+500
+8% +$76.4K 0.45% 50
2016
Q4
$861 Hold
6,100
0.3% 58
2016
Q3
$971K Hold
6,100
0.44% 51
2016
Q2
$902K Buy
6,100
+2,800
+85% +$413K 0.46% 52
2016
Q1
$467K Sell
3,300
-300
-8% -$40.2K 0.21% 88
2015
Q4
$511K Buy
+3,600
New +$480K 0.27% 79

Other funds holding TMO

Truvvo Partners's TMO Position: Q4 2018 in Review

Truvvo Partners sold out of Thermo Fisher Scientific (TMO) in Q4 2018, closing a stake of 2,500 shares — an estimated $611K sold.

Truvvo Partners first reported a position in TMO in Q4 2015 and held it in 12 quarters. The position peaked at $1.36M in Q1 2018. 1,457 funds tracked by Wall St. Rank hold TMO as of Q4 2018.

  • Truvvo Partners reported no remaining Thermo Fisher Scientific position as of Q4 2018 after selling out during the quarter.
  • Truvvo Partners sold 2,500 Thermo Fisher Scientific shares in Q4 2018, an estimated $611K.
  • Truvvo Partners first reported a position in Thermo Fisher Scientific in Q4 2015 and held it in 12 quarters.
  • Truvvo Partners's Thermo Fisher Scientific position peaked at $1.36M in Q1 2018.
  • 1,457 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2018.

Based on Truvvo Partners's 13F filing for Q4 2018, filed 14 Feb 2019.